Study Type
Interventional - Procedure
ongoing
The objective of the BRAVE pilot study is to demonstrate the feasibility of enrolling patients with high-risk cardiovascular disease (CVD) into a randomized controlled trial of bariatric surgery versus medical weight management (MWM).
Sixty patients will be recruited from ambulatory cardiology clinics affiliated with two Bariatric Centres of Excellence in Ontario:
- St. Joseph’s Healthcare, Hamilton
- Ottawa Civic Hospital, Ottawa
Study Design
Open-label, parallel-arm RCT
NO. of Countries
1
NO. of Sites
2
NO. of Participants
60
Study Period
2020 - 2023
Sponsor
PHRI
Jorge Wong
Investigator
Jorge Wong
Investigator
Jorge Wong is a cardiologist and cardiac electrophysiologist at Hamilton Health Sciences, as well as an investigator in the Arrhythmia and Heart Failure program at PHRI. His research interests focus primarily on the intersection between atrial fibrillation and heart failure, atrial fibrillation epidemiology and catheter ablation for atrial fibrillation. He holds research grants from the Heart and Stroke Foundation of Canada, the Canadian Cardiovascular Society, and Hamilton Health Sciences.
He obtained his MD at McMaster, followed by his internal medicine and cardiology training at the University of Western Ontario. Jorge subsequently completed his clinical electrophysiology fellowship at the University of Calgary and at the Brigham and Women’s Hospital in Boston. He has a Master of Public Health degree from the Harvard School of Public Health, and is currently pursuing his PhD in Health Research Methods at McMaster.
Tara McCready
Program Director
Tara McCready
Program Director
Tara McCready, PhD, oversees a variety of collaborative programs at PHRI, and serves as Project Manager for PHRI research studies and registries.
She was recruited to PHRI as a Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN), a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes.
Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Tara holds a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.
